Don’t Blink: 9th Circuit Issues Pivotal Decision on Enforcement of CSA Against Cannabis-ness
DEA Keeps Marijuana in Schedule I While Expanding Access for Research and Clarifying Rules on Hemp
FDA Notifies Applicants of Intent to Require Sweeping Changes to Labeling for IR Opioid Analgesics and Entire Class of Prescription Opioids
FDA Publishes Draft Guidances and Memorandum of Understanding on Drug Compounding and Repackaging
Subscribe: Subscribe via RSS
Blogs
Firm/Org